Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Stomatitis 2Nasopharyngeal Carcinoma 2Head and Neck Neoplasms 2Thyroid Diseases 1Nasopharyngeal Neoplasms 1Laryngeal Diseases 1

Interventions

Low-Level Light Therapy 6Cisplatin 5avasopasem manganese 4Radiotherapy, Intensity-Modulated 4Standard of Care 3Injections 3Fibroblast Growth Factor 7 3golotimod 2Water 2Vitamin B 12 2Sodium Bicarbonate 2Saline Solution 2Radiotherapy 2RRx-001 2Propolis 2Mouthwashes 2Honey 2Gentamicins 2whole grape extract 1sargramostim 1samital 1regramostim 1oxycodone-acetaminophen 1dusquetide 1clazakizumab 1brilacidin 1alfacalcidol 1Xylitol 1Valacyclovir 1Traumeel S 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Stomatitis × Vitamin B 12 × Head & Neck × Clear all
NCT03778008 2018-12-27

Recombinant Bovine Basic Fibroblast Growth Factor for the Treatment of Radiation Induced Oral Mucositis

Second Affiliated Hospital of Nanchang University

Phase 2 Unknown
90 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Stomatitis

NCT02735317 2016-04-12

Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT

Sun Yat-sen University

Phase 2 Unknown
90 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms, Stomatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡